XLVI vs. TMED
XLVI (State Street Health Care Select Sector SPDR Premium Income ETF) and TMED (T. Rowe Price Health Care ETF) are both exchange-traded funds - XLVI is a Derivative Income fund actively managed by State Street, while TMED is a Health & Biotech Equities fund managed by T. Rowe Price. Their correlation of 0.85 suggests significant overlap in exposure. XLVI charges 0.35%/yr vs 0.44%/yr for TMED.
Performance
XLVI vs. TMED - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XLVI achieves a -1.33% return, which is significantly lower than TMED's 2.81% return.
XLVI
- 1D
- -0.73%
- 1M
- 1.42%
- YTD
- -1.33%
- 6M
- 0.46%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
TMED
- 1D
- -2.33%
- 1M
- 1.95%
- YTD
- 2.81%
- 6M
- 4.16%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
XLVI vs. TMED - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
XLVI State Street Health Care Select Sector SPDR Premium Income ETF | -1.33% | 12.79% |
TMED T. Rowe Price Health Care ETF | 2.81% | 21.62% |
Correlation
The correlation between XLVI and TMED is 0.85, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Jul 31, 2025 | 0.85 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XLVI vs. TMED - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for State Street Health Care Select Sector SPDR Premium Income ETF (XLVI) and T. Rowe Price Health Care ETF (TMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| XLVI | TMED | Difference | |
|---|---|---|---|
Sharpe Ratio (All Time)Calculated using the full available price history | 1.25 | 1.29 | -0.04 |
Drawdowns
XLVI vs. TMED - Drawdown Comparison
The maximum XLVI drawdown since its inception was -8.14%, smaller than the maximum TMED drawdown of -11.11%. Use the drawdown chart below to compare losses from any high point for XLVI and TMED.
Loading charts...
Drawdown Indicators
| XLVI | TMED | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -8.14% | -11.11% | +2.97% |
Current DrawdownCurrent decline from peak | -4.66% | -3.75% | -0.91% |
Average DrawdownAverage peak-to-trough decline | -1.94% | -2.59% | +0.65% |
Volatility
XLVI vs. TMED - Volatility Comparison
Loading charts...
Volatility by Period
| XLVI | TMED | Difference | |
|---|---|---|---|
Volatility (1Y)Calculated over the trailing 1-year period | 10.94% | 18.05% | -7.11% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 10.94% | 18.05% | -7.11% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 10.94% | 18.05% | -7.11% |
XLVI vs. TMED - Expense Ratio Comparison
XLVI has a 0.35% expense ratio, which is lower than TMED's 0.44% expense ratio.
Dividends
XLVI vs. TMED - Dividend Comparison
XLVI's dividend yield for the trailing twelve months is around 11.61%, more than TMED's 0.53% yield.
| Position | TTM | 2025 |
|---|---|---|
TMED T. Rowe Price Health Care ETF | 0.53% | 0.54% |
XLVI State Street Health Care Select Sector SPDR Premium Income ETF | 11.61% | 5.73% |
Frequently Asked Questions
XLVI and TMED have a correlation of 0.85, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, XLVI is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XLVI is cheaper with a 0.35% expense ratio, compared with 0.44% for TMED.
XLVI has the higher dividend yield at 11.61%, compared with 0.53% for TMED.
XLVI is categorized as Derivative Income, while TMED is Health & Biotech Equities. They also come from different issuers: State Street and T. Rowe Price. Their fees differ too: 0.35% for XLVI and 0.44% for TMED.
Find the right allocation for XLVI and TMED
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer